Spots Global Cancer Trial Database for lv
Every month we try and update this database with for lv cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Dose Escalation and Expansion Clinical Trial of Irinotecan Liposome Combined With Oxaliplatin and 5-FU/LV Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer | NCT06225622 | Metastatic Colo... | Irinotecan Lipo... Oxaliplatin 5-FU LV Bevacizumab Cetuximab | 18 Years - 75 Years | Shanghai Zhongshan Hospital | |
| Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer | NCT00036517 | Colorectal Neop... Diarrhea | PHY906 | 18 Years - 75 Years | PhytoCeutica | |
| Study of Gamma Interfereon in Metastatic Colorectal Carcinoma | NCT00786643 | Colorectal Canc... | 5-Fluorouracil Leucovorin (LV) Gamma-Interfero... Bevacizumab | 18 Years - | Accelerated Community Oncology Research Network | |
| Perioperative Treatment in High-risk Resectable Pancreatic Cancer With NALIRIFOX | NCT06210360 | Pancreatic Canc... | Irinotecan lipo... Oxaliplatin 5-FU LV | 18 Years - | Changhai Hospital | |
| Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer Patients | NCT00354978 | Colorectal Canc... | 5-Fluorouracil Bevacizumab Leucovorin Irinotecan | 18 Years - | M.D. Anderson Cancer Center | |
| Study of Gamma Interfereon in Metastatic Colorectal Carcinoma | NCT00786643 | Colorectal Canc... | 5-Fluorouracil Leucovorin (LV) Gamma-Interfero... Bevacizumab | 18 Years - | Accelerated Community Oncology Research Network | |
| Dose Escalation and Expansion Clinical Trial of Irinotecan Liposome Combined With Oxaliplatin and 5-FU/LV Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer | NCT06225622 | Metastatic Colo... | Irinotecan Lipo... Oxaliplatin 5-FU LV Bevacizumab Cetuximab | 18 Years - 75 Years | Shanghai Zhongshan Hospital | |
| A Study of PEP02 in Combination With 5-fluorouracil (5-FU) and Leucovorin (LV) in Advanced Solid Tumors | NCT02884128 | Solid Tumor | PEP02 5-FU LV | 20 Years - 70 Years | PharmaEngine | |
| Liposomal Irinotecan and Leucovorin/5-fluorouracil Plus Bevacizumab in Metastatic Colorectal Cancer | NCT06184698 | Colorectal Canc... | liposomal irino... 5-FU LV Bevacizumab | 18 Years - 80 Years | Hebei Medical University Fourth Hospital | |
| Dose Escalation and Expansion Clinical Trial of Irinotecan Liposome Combined With Oxaliplatin and 5-FU/LV Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer | NCT06225622 | Metastatic Colo... | Irinotecan Lipo... Oxaliplatin 5-FU LV Bevacizumab Cetuximab | 18 Years - 75 Years | Shanghai Zhongshan Hospital | |
| Liposomal Irinotecan and Leucovorin/5-fluorouracil Plus Bevacizumab in Metastatic Colorectal Cancer | NCT06184698 | Colorectal Canc... | liposomal irino... 5-FU LV Bevacizumab | 18 Years - 80 Years | Hebei Medical University Fourth Hospital | |
| Study of S-1 Plus LV for Advanced Gastric Cancer | NCT02090153 | Gastric Cancer | S-1 LV | 18 Years - | Sun Yat-sen University | |
| Safety and Effectiveness Study of Chemotherapy and Ziv-aflibercept to Treat Metastatic Colorectal Cancer | NCT01889680 | Colorectal Canc... Metastatic Colo... | 5-FU LV ziv-aflibercept mFOLFOX6 | 18 Years - | NSABP Foundation Inc | |
| Safety and Effectiveness Study of Chemotherapy and Ziv-aflibercept to Treat Metastatic Colorectal Cancer | NCT01889680 | Colorectal Canc... Metastatic Colo... | 5-FU LV ziv-aflibercept mFOLFOX6 | 18 Years - | NSABP Foundation Inc |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
